Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T M McIntyre

Showing results (141-150 of 152) with videos related to

Pageof 16
Sort By:
Nature|February 22, 1990
Rapid neutrophil adhesion to activated endothelium mediated by GMP-140J G Geng, M P Bevilacqua, K L Moore, et al.
Journal of Lipid Research|April 6, 2001
Identification of platelet-activating factor as the inflammatory lipid mediator in CCl4-metabolizing rat liverG K Marathe, K A Harrison, L J Roberts, et al.
The Journal of Biological Chemistry|September 25, 1999
Inflammatory platelet-activating factor-like phospholipids in oxidized low density lipoproteins are fragmented alkyl phosphatidylcholinesG K Marathe, S S Davies, K A Harrison, et al.
Circulation Research|September 15, 2001
Differential regulation of matrix metalloproteinase-9 by monocytes adherent to collagen and plateletsS W Galt, S Lindemann, D Medd, et al.
The Journal of Clinical Investigation|February 1, 1995
Effect of platelet activating factor-acetylhydrolase on the formation and action of minimally oxidized low density lipoproteinA D Watson, M Navab, S Y Hama, et al.
The Journal of Clinical Investigation|December 1, 1995
Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response. Loss of protective effect of HDL against LDL oxidation in aortic wall cell coculturesB J Van Lenten, S Y Hama, F C de Beer, et al.
Advances in Experimental Medicine and Biology|January 1, 1996
Functional and structural features of plasma platelet-activating factor acetylhydrolaseL W Tjoelker, C Eberhardt, C Wilder, et al.
The Journal of Clinical Investigation|June 15, 1996
Platelet-activating factor acetylhydrolase deficiency. A missense mutation near the active site of an anti-inflammatory phospholipaseD M Stafforini, K Satoh, D L Atkinson, et al.
The Journal of Biological Chemistry|March 30, 2001
Oxidized alkyl phospholipids are specific, high affinity peroxisome proliferator-activated receptor gamma ligands and agonistsS S Davies, A V Pontsler, G K Marathe, et al.
Nature|April 6, 1995
Anti-inflammatory properties of a platelet-activating factor acetylhydrolaseL W Tjoelker, C Wilder, C Eberhardt, et al.
Pageof 16

Showing results (141-150 of 152) with videos related to

Sort By:
Pageof 16
Nature|February 22, 1990
Rapid neutrophil adhesion to activated endothelium mediated by GMP-140J G Geng, M P Bevilacqua, K L Moore, et al.
Journal of Lipid Research|April 6, 2001
Identification of platelet-activating factor as the inflammatory lipid mediator in CCl4-metabolizing rat liverG K Marathe, K A Harrison, L J Roberts, et al.
The Journal of Biological Chemistry|September 25, 1999
Inflammatory platelet-activating factor-like phospholipids in oxidized low density lipoproteins are fragmented alkyl phosphatidylcholinesG K Marathe, S S Davies, K A Harrison, et al.
Circulation Research|September 15, 2001
Differential regulation of matrix metalloproteinase-9 by monocytes adherent to collagen and plateletsS W Galt, S Lindemann, D Medd, et al.
The Journal of Clinical Investigation|February 1, 1995
Effect of platelet activating factor-acetylhydrolase on the formation and action of minimally oxidized low density lipoproteinA D Watson, M Navab, S Y Hama, et al.
The Journal of Clinical Investigation|December 1, 1995
Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response. Loss of protective effect of HDL against LDL oxidation in aortic wall cell coculturesB J Van Lenten, S Y Hama, F C de Beer, et al.
Advances in Experimental Medicine and Biology|January 1, 1996
Functional and structural features of plasma platelet-activating factor acetylhydrolaseL W Tjoelker, C Eberhardt, C Wilder, et al.
The Journal of Clinical Investigation|June 15, 1996
Platelet-activating factor acetylhydrolase deficiency. A missense mutation near the active site of an anti-inflammatory phospholipaseD M Stafforini, K Satoh, D L Atkinson, et al.
The Journal of Biological Chemistry|March 30, 2001
Oxidized alkyl phospholipids are specific, high affinity peroxisome proliferator-activated receptor gamma ligands and agonistsS S Davies, A V Pontsler, G K Marathe, et al.
Nature|April 6, 1995
Anti-inflammatory properties of a platelet-activating factor acetylhydrolaseL W Tjoelker, C Wilder, C Eberhardt, et al.
Pageof 16